These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1995721)

  • 1. A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population.
    Santosham M; Letson GW; Wolff M; Reid R; Gahagan S; Adams R; Callahan C; Sack RB; Kapikian AZ
    J Infect Dis; 1991 Mar; 163(3):483-7. PubMed ID: 1995721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations.
    Santosham M; Moulton LH; Reid R; Croll J; Weatherholt R; Ward R; Forro J; Zito E; Mack M; Brenneman G; Davidson BL
    J Pediatr; 1997 Oct; 131(4):632-8. PubMed ID: 9386673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine.
    Vesikari T; Isolauri E; D'Hondt E; Delem A; André FE; Zissis G
    Lancet; 1984 May; 1(8384):977-81. PubMed ID: 6143964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela.
    Pérez-Schael I; Guntiñas MJ; Pérez M; Pagone V; Rojas AM; González R; Cunto W; Hoshino Y; Kapikian AZ
    N Engl J Med; 1997 Oct; 337(17):1181-7. PubMed ID: 9337376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of two doses of RIT 4237 bovine rotavirus vaccine for prevention of rotavirus diarrhoea.
    Vesikari T; Ruuska T; Delem A; André FE; Beards GM; Flewett TH
    Acta Paediatr Scand; 1991 Feb; 80(2):173-80. PubMed ID: 1852084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
    Bernstein DI; Glass RI; Rodgers G; Davidson BL; Sack DA
    JAMA; 1995 Apr; 273(15):1191-6. PubMed ID: 7707626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine.
    Perez-Schael I; Garcia D; Gonzalez M; Gonzalez R; Daoud N; Perez M; Cunto W; Kapikian AZ; Flores J
    J Med Virol; 1990 Mar; 30(3):219-29. PubMed ID: 2160516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants.
    Flores J; Perez-Schael I; Gonzalez M; Garcia D; Perez M; Daoud N; Cunto W; Chanock RM; Kapikian AZ
    Lancet; 1987 Apr; 1(8538):882-4. PubMed ID: 2882289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.
    Joensuu J; Koskenniemi E; Pang XL; Vesikari T
    Lancet; 1997 Oct; 350(9086):1205-9. PubMed ID: 9652561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
    Vesikari T; Rautanen T; Varis T; Beards GM; Kapikian AZ
    Am J Dis Child; 1990 Mar; 144(3):285-9. PubMed ID: 2154925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru.
    Lanata CF; Black RE; Flores J; Lazo F; Butron B; Linares A; Huapaya A; Ventura G; Gil A; Kapikian AZ
    Vaccine; 1996 Feb; 14(3):237-43. PubMed ID: 8920706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. The Maryland Clinical Studies Group.
    Pichichero ME; Losonsky GA; Rennels MB; Disney FA; Green JL; Francis AB; Marsocci SM
    Pediatr Infect Dis J; 1990 May; 9(5):339-44. PubMed ID: 2162027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa.
    Georges-Courbot MC; Monges J; Siopathis MR; Roungou JB; Gresenguet G; Bellec L; Bouquety JC; Lanckriet C; Cadoz M; Hessel L
    Res Virol; 1991; 142(5):405-11. PubMed ID: 1663261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of bovine rotavirus vaccine RIT 4237 in 3-month-old infants.
    Maldonado Y; Hestvik L; Wilson M; Townsend T; O'Hare J; Wee S; Yolken R
    J Pediatr; 1986 Dec; 109(6):931-5. PubMed ID: 3537248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.
    Kapikian AZ; Flores J; Hoshino Y; Midthun K; Gorziglia M; Green KY; Chanock RM; Potash L; Sears SD; Clements ML
    Rev Infect Dis; 1989; 11 Suppl 3():S539-46. PubMed ID: 2548276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period.
    Ruuska T; Vesikari T; Delem A; André FE; Beards GM; Flewett TH
    Scand J Infect Dis; 1990; 22(3):269-78. PubMed ID: 2164706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of human rotavirus vaccine on severe diarrhea in African infants.
    Madhi SA; Cunliffe NA; Steele D; Witte D; Kirsten M; Louw C; Ngwira B; Victor JC; Gillard PH; Cheuvart BB; Han HH; Neuzil KM
    N Engl J Med; 2010 Jan; 362(4):289-98. PubMed ID: 20107214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.
    Ruiz-Palacios GM; Pérez-Schael I; Velázquez FR; Abate H; Breuer T; Clemens SC; Cheuvart B; Espinoza F; Gillard P; Innis BL; Cervantes Y; Linhares AC; López P; Macías-Parra M; Ortega-Barría E; Richardson V; Rivera-Medina DM; Rivera L; Salinas B; Pavía-Ruz N; Salmerón J; Rüttimann R; Tinoco JC; Rubio P; Nuñez E; Guerrero ML; Yarzábal JP; Damaso S; Tornieporth N; Sáez-Llorens X; Vergara RF; Vesikari T; Bouckenooghe A; Clemens R; De Vos B; O'Ryan M;
    N Engl J Med; 2006 Jan; 354(1):11-22. PubMed ID: 16394298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants.
    Joensuu J; Koskenniemi E; Vesikari T
    Pediatr Infect Dis J; 1998 Apr; 17(4):334-40. PubMed ID: 9576390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An efficacy trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group.
    Rennels MB; Losonsky GA; Young AE; Shindledecker CL; Kapikian AZ; Levine MM
    Am J Dis Child; 1990 May; 144(5):601-4. PubMed ID: 2330930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.